tiprankstipranks
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market
Holding LYEL?
Track your performance easily

Lyell Immunopharma (LYEL) Ownership - Who Owns Lyell Immunopharma?

92 Followers

Lyell Immunopharma (LYEL) Ownership Overview

17.75%9.55%25.65%7.40%39.65%
17.75% Insiders
25.65% Other Institutional Investors
7.40% ETFs
39.65% Public Companies and
Individual Investors
The ownership structure of Lyell Immunopharma (LYEL) stock is a mix of institutional, retail, and individual investors. Approximately 42.60% of the company’s stock is owned by Institutional Investors, 17.75% is owned by Insiders, and 39.65% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$287034

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
36,477,716Insider14.50%33,413,588
11,806,630Institution4.23%10,814,873
9,611,762Institution3.44%8,804,374
8,515,721Institution3.05%7,800,400
5,921,942Institution2.12%5,424,499
4,685,614Insider1.68%4,292,022
3,653,199Insider1.31%3,346,330
1,872,361Institution0.67%1,715,083
1,699,230Institution0.61%1,556,495
1,147,315Institution0.41%1,050,941

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
11,806,630Institution4.23%10,814,873
5,921,942Institution2.12%5,424,499
1,872,361Institution0.67%1,715,083
1,699,230Institution0.61%1,556,495
1,147,315Institution0.41%1,050,941
942,414Institution0.34%863,251
767,436Institution0.27%702,971
441,172Institution0.16%404,114
419,906Institution0.15%384,634
286,014Institution0.10%261,989

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,817,818Institution2.08%5,586,851
4,518,244Institution1.62%4,141,422
2,522,865Institution0.90%2,422,707
1,572,519Institution0.56%1,441,371
769,461Institution0.28%792,545
788,258Institution0.28%722,517
732,499Institution0.26%703,419
417,543Institution0.15%400,967
364,118Institution0.13%333,751
340,395Institution0.12%312,006

FAQ

Who Owns Lyell Immunopharma (LYEL)?
According to the latest TipRanks data, approximately 25.65% of the company's stock is held by institutional investors, 17.75% is held by insiders, and 39.65% is held by retail investors.
    What percentage of Lyell Immunopharma (LYEL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 25.65% of Lyell Immunopharma (LYEL) stock is held by institutional investors.
      What percentage of Lyell Immunopharma (LYEL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 39.65% of Lyell Immunopharma (LYEL) stock is held by retail investors.
        Who owns the most shares of Lyell Immunopharma (LYEL)?
        Robert Nelsen owns the most shares of Lyell Immunopharma (LYEL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis